Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease

OBJECTIVE: To evaluate the characteristics of patients with autoimmune disease with hypogammaglobulinemia following rituximab (RTX) and describe their long-term outcomes, including those who commenced immunoglobulin replacement therapy. METHODS: Patients received RTX for autoimmune disease between 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Tieu, Joanna, Smith, Rona M., Gopaluni, Seerapani, Kumararatne, Dinakantha S., McClure, Mark, Manson, Ania, Houghton, Sally, Jayne, David R. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149951/
https://www.ncbi.nlm.nih.gov/pubmed/34054846
http://dx.doi.org/10.3389/fimmu.2021.671503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149951/
https://www.ncbi.nlm.nih.gov/pubmed/34054846
http://dx.doi.org/10.3389/fimmu.2021.671503

Ejemplares similares